查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771031

兽医 CRO 和 CDMO 市场 - 全球产业规模、份额、趋势、机会和预测（按动物、服务、应用、地区和竞争细分，2020-2030 年）

Veterinary CRO And CDMO Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Animal, By Service, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 184 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球兽医合约研究组织 (CRO) 和合约製造生产组织 (CDMO) 市场规模预计在 2024 年达到 57.8 亿美元，到 2030 年将达到 96.5 亿美元，年复合成长率为 8.90%。製药和生物技术公司越来越多地将研发和生产外包，以减轻营运负担并加快进度，这推动了这一成长。兽医治疗药物、疫苗和生物製剂的需求不断增长，尤其是伴侣动物和牲畜的需求，这加剧了对成本效益高且合规的合约组织的需求。合约研究组织 (CRO) 支援临床和监管职能，而合约製造生产组织 (CDMO) 则提供从製剂到商业生产的全方位服务。此外，人畜共通传染病和传染病威胁的激增也加大了动物保健领域的研发投入，从而刺激了专业外包合作伙伴市场的发展。影响市场的一个主要趋势是 CRO、CDMO 和兽药开发商之间的策略合作和收购不断增加，这是由扩大全球影响力和在临床研究中整合数位工具和生物标记研究等技术支援平台的需求所推动的。

市场概览
预测期 2026-2030
2024年市场规模 57.8亿美元
2030年市场规模 96.5亿美元
2025-2030 年复合年增长率 8.90%
成长最快的领域 医疗器材
最大的市场 北美洲

关键市场驱动因素

伴侣动物拥有量和医疗保健支出的增加

主要市场挑战

熟练兽医研究专业人员数量有限

主要市场趋势

生物製剂和先进兽医治疗药物的需求增加

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球兽医CRO与CDMO市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 按动物（伴侣动物、牲畜）
    • 按服务（发现、开发、製造、包装和标籤、市场批准和上市后）
    • 依应用（药品、生物製剂、医疗器材、其他）
    • 按公司分类（2024）
    • 按地区
  • 市场地图

第六章：北美兽医CRO与CDMO市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第七章：欧洲兽医CRO和CDMO市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太兽医CRO和CDMO市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲

第九章：南美兽医CRO和CDMO市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第十章：中东和非洲兽医CRO和CDMO市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如有）
  • 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 15 章：竞争格局

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet (Pty) Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

第 16 章：策略建议

第17章调查会社について・免责事项

简介目录
Product Code: 29982

The Global Veterinary CRO and CDMO Market, valued at USD 5.78 Billion in 2024, is projected to reach USD 9.65 Billion by 2030, growing at a CAGR of 8.90%. This growth is fueled by the increasing tendency of pharmaceutical and biotechnology firms to outsource research, development, and manufacturing to reduce operational loads and accelerate timelines. Rising demand for veterinary therapeutics, vaccines, and biologics-particularly for companion animals and livestock-has amplified the need for cost-efficient and compliant contract organizations. CROs support clinical and regulatory functions, while CDMOs offer full-spectrum services from formulation to commercial manufacturing. Additionally, the surge in zoonotic diseases and infectious threats has intensified R&D investments in animal health, boosting the market for specialized outsourcing partners. A major trend influencing the market is the uptick in strategic collaborations and acquisitions among CROs, CDMOs, and veterinary drug developers, driven by the need to broaden global presence and integrate tech-enabled platforms like digital tools and biomarker studies in clinical research.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 5.78 Billion
Market Size 2030USD 9.65 Billion
CAGR 2025-20308.90%
Fastest Growing SegmentMedical Devices
Largest MarketNorth America

Key Market Drivers

Increase in Companion Animal Ownership and Healthcare Spending

The growing number of companion animals and rising expenditure on their healthcare are pivotal factors driving the Veterinary CRO and CDMO market. Increasingly, pets are being viewed as family members, reshaping consumer spending patterns. According to the 2024 Pet Ownership Survey by the American Veterinary Medical Association, 45.5% of U.S. households own dogs and 32.1% own cats-amounting to nearly 90 million dogs and 74 million cats. Annual veterinary spending averages USD 580 per dog and USD 433 per cat. This surge in pet population and associated healthcare costs has led pharmaceutical and biotech companies to expand their veterinary pipelines, thereby increasing the demand for outsourced R&D and manufacturing services.

Key Market Challenges

Limited Availability of Skilled Veterinary Research Professionals

A significant hurdle in the Global Veterinary CRO and CDMO Market is the shortage of skilled veterinary research professionals. Veterinary clinical and preclinical studies require specialized knowledge across diverse species, drug mechanisms, behavioral patterns, and compliance standards. Unlike human trials, veterinary research spans a wide array of animals-companion pets, livestock, equines, and exotic species-each with unique biological needs. This diversity demands expertise in veterinary science, clinical trial methodologies, ethical considerations, and animal care protocols. However, a global shortfall of such multidisciplinary professionals hampers the scalability, timeline adherence, and quality maintenance capabilities of CROs and CDMOs.

Key Market Trends

Increased Demand for Biologics and Advanced Veterinary Therapeutics

The demand for biologics and next-generation veterinary therapeutics is significantly shaping the Veterinary CRO and CDMO market. As animal health issues become more complex, there's a growing preference for high-efficacy biologics like monoclonal antibodies, recombinant proteins, and DNA-based vaccines over traditional small-molecule drugs. These innovative solutions are being developed to address serious conditions such as cancer, autoimmune diseases, and chronic infections in both companion and farm animals. This trend is expanding the need for specialized services from CROs and CDMOs, including immunogenicity evaluations, bioanalytical testing, and biologics manufacturing under high-containment protocols. The advanced infrastructure and analytical capabilities required for biologics are fueling the reliance on expert contract organizations.

Key Market Players

  • Fortrea Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Clinvet (Pty) Ltd.
  • KLIFOVET GmbH
  • Veterinary Research Management, Inc.
  • VETSPIN SRL
  • Inotiv, Inc.
  • IDEXX Laboratories, Inc.
  • Vetio Animal Health
  • TriRx Pharmaceutical Services, LLC

Report Scope:

In this report, the Global Veterinary CRO And CDMO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary CRO And CDMO Market, By Animal:

  • Companion Animals
  • Livestock Animals

Veterinary CRO And CDMO Market, By Service:

  • Discovery
  • Development
  • Manufacturing
  • Packaging & Labeling
  • Market Approval & Post Marketing

Veterinary CRO And CDMO Market, By Application:

  • Pharmaceuticals
  • Biologics
  • Medical Devices
  • Others

Veterinary CRO And CDMO Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary CRO And CDMO Market.

Available Customizations:

Global Veterinary CRO And CDMO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Veterinary CRO And CDMO Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Animal (Companion Animals, Livestock Animals)
    • 5.2.2. By Service (Discovery, Development, Manufacturing, Packaging & Labeling, Market Approval & Post Marketing)
    • 5.2.3. By Application (Pharmaceuticals, Biologics, Medical Devices, Others)
    • 5.2.4. By Company (2024)
    • 5.2.5. By Region
  • 5.3. Market Map

6. North America Veterinary CRO And CDMO Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Animal
    • 6.2.2. By Service
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Veterinary CRO And CDMO Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Animal
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Application
    • 6.3.2. Mexico Veterinary CRO And CDMO Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Animal
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Application
    • 6.3.3. Canada Veterinary CRO And CDMO Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Animal
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Application

7. Europe Veterinary CRO And CDMO Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Animal
    • 7.2.2. By Service
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Veterinary CRO And CDMO Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Animal
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Veterinary CRO And CDMO Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Animal
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Veterinary CRO And CDMO Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Animal
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Veterinary CRO And CDMO Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Animal
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Veterinary CRO And CDMO Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Animal
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Application

8. Asia-Pacific Veterinary CRO And CDMO Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Animal
    • 8.2.2. By Service
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Veterinary CRO And CDMO Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Animal
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Application
    • 8.3.2. India Veterinary CRO And CDMO Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Animal
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Application
    • 8.3.3. South Korea Veterinary CRO And CDMO Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Animal
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Application
    • 8.3.4. Japan Veterinary CRO And CDMO Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Animal
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Veterinary CRO And CDMO Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Animal
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Application

9. South America Veterinary CRO And CDMO Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Animal
    • 9.2.2. By Service
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Veterinary CRO And CDMO Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Animal
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Veterinary CRO And CDMO Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Animal
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Veterinary CRO And CDMO Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Animal
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Application

10. Middle East and Africa Veterinary CRO And CDMO Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Animal
    • 10.2.2. By Service
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Veterinary CRO And CDMO Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Animal
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Veterinary CRO And CDMO Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Animal
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Veterinary CRO And CDMO Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Animal
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Fortrea Holdings Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Charles River Laboratories International, Inc.
  • 15.3. Clinvet (Pty) Ltd.
  • 15.4. KLIFOVET GmbH
  • 15.5. Veterinary Research Management, Inc.
  • 15.6. VETSPIN SRL
  • 15.7. Inotiv, Inc.
  • 15.8. IDEXX Laboratories, Inc.
  • 15.9. Vetio Animal Health
  • 15.10. TriRx Pharmaceutical Services, LLC

16. Strategic Recommendations

17. About Us & Disclaimer